Genetic and epigenetic mechanisms and clinicopathological significance of the silencing of a 6q22.33-q23.2 putative tumor suppressor PTPRK (protein tyrosine phosphatase, receptor type, kappa) gene in extranodal NK/T-cell lymphoma, nasal type

View Statistics Email Alert RSS Feed

Grant Data
Project Title
Genetic and epigenetic mechanisms and clinicopathological significance of the silencing of a 6q22.33-q23.2 putative tumor suppressor PTPRK (protein tyrosine phosphatase, receptor type, kappa) gene in extranodal NK/T-cell lymphoma, nasal type
Principal Investigator
Professor Srivastava, Gopesh   (Principal Investigator (PI))
Co-Investigator(s)
Duration
36
Start Date
2007-09-01
Amount
1448992
Conference Title
Genetic and epigenetic mechanisms and clinicopathological significance of the silencing of a 6q22.33-q23.2 putative tumor suppressor PTPRK (protein tyrosine phosphatase, receptor type, kappa) gene in extranodal NK/T-cell lymphoma, nasal type
Presentation Title
Keywords
6q22.33-q23.2, Nasal lymphoma, NK-cell lymphoma, PTPRK, Tumor suppressor
Discipline
Pathology,Blood/Hematology
HKU Project Code
HKU 775607M
Grant Type
General Research Fund (GRF)
Funding Year
2007
Status
Completed